retatrutide news today october 2025 (Eli Lilly's triple GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the phase 3 TRIUMPH-4 trial: Breaking news: Lilly’s triple agonist
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12












:format(jpg)/f.elconfidencial.com%2Foriginal%2Ff27%2Fb3a%2F460%2Ff27b3a460e92bcdc8635b6aa1b0eff12.jpg)












![Shining Celebi (106/105) [Neo Destiny Unlimited] Vanguard](https://cdn.shopify.com/s/files/1/0467/0206/7875/products/b41ca381-7314-44f2-ab7a-e15d140cde63.jpg?v=1636072646)
